CrystalGenomics to Participate in 2021 J.P. Morgan Healthcare Conference
[Asia Economy Reporter Hyunseok Yoo] CrystalGenomics announced on the 9th that it has been invited to the '2021 J.P. Morgan Healthcare Conference' held in San Francisco, USA. The company will introduce its research and development (R&D) status through video meetings from January 11 to 14 next year (local time).
At this 39th conference, the largest global pharmaceutical and biotech company and investor meeting at the beginning of the year, more than 10,000 people from over 500 companies worldwide will attend to share corporate information and discuss fundraising and technology transfers.
CrystalGenomics plans to present data on Ivaltinostat, a new drug candidate for cancer and anti-fibrosis treatment, targeting investors and global bio-pharmaceutical companies.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
Through one-on-one video meetings, the company plans to conduct partnership consultations and discuss joint research and development. A CrystalGenomics official said, "At the J.P. Morgan Healthcare Conference, we plan to promote strategic partnerships by introducing our innovative new drug development pipeline and global clinical trials."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
